Anesthesia and critical care of thymectomy for myasthenia gravis

Chest Surgery Clinics of North America

Volumn 11, Issue 2, 2001, Pages 337-361

  Baraka, A ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIBODY; CHOLINERGIC RECEPTOR; HALOTHANE; ISOFLURANE; MUSCLE RELAXANT AGENT; SEVOFLURANE; SUXAMETHONIUM;

ANESTHESIA INDUCTION; ANTIBODY PRODUCTION; ARTIFICIAL VENTILATION; AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSARTHRIA; DYSPHAGIA; ENDOTRACHEAL INTUBATION; HUMAN; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; OPERATION DURATION; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SURGICAL RISK; THYMECTOMY; THYMOMA; TREATMENT PLANNING;

ANESTHESIA; CRITICAL CARE; HUMANS; MONITORING, INTRAOPERATIVE; MYASTHENIA GRAVIS; POSTOPERATIVE COMPLICATIONS; THORACIC SURGERY, VIDEO-ASSISTED; THYMECTOMY; TREATMENT OUTCOME;

EID: 0034995108     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Anaesthesia and myasthenia gravis
2. Neuromuscular effects of halothane, suxamethonium and tubocurarine in a myasthenic undergoing thymectomy
3. Hazards of carbon dioxide insufflation during thoracoscopy
4. Apnea-induced hemoglobin desaturation during one-lung versus two-lung ventilation
5. Ambient pressure oxygenation via the nonventilated lung during video-assisted thoracoscopy
6. Repeated doses of suxamethonium in the myasthenic patient
7. Suxamethonium block in the myasthenic patient: Correlation with plasma cholinesterase
8. Atracurium in myasthenics undergoing thymectomy
9. Neuromuscular response to succinylcholine-vecuronium sequence in three myasthenic patients undergoing thymectomy
10. CPAP oxygenation during OLV using an underwater seal assembly
11. Cisatracurium in a myasthenic patient undergoing thymectomy
12. Irreversible tubocurarine neuromuscular block in the human
13. One-lung ventilation and hypoxic pulmonary vasoconstriction: Implications for anesthetic management
14. The role of the thymus in myasthenia gravis: Immunohistological and immunological studies in 115 cases
15. Myasthenia gravis and tumors of the thymic region. Report of a case in which the tumor was removed
16. Anesthesia and neuromuscular diseases
17. Vecuronium for muscle relaxation in patients with myasthenia gravis
18. Optimization of arterial oxygenation during one-lung anesthesia
19. 2
20. An improved technique to facilitate transcervical thymectomy for myasthenia gravis
21. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis
22. Myasthenia gravis
23. Humoral pathogenesis of myasthenia gravis
24. Strategies for the treatment of myasthenia gravis
25. Anaesthesia for thymectomy in myasthenia gravis: A non-muscle-relaxant technique
26. Resistance to succinylcholine in myasthenia gravis: A dose-response study
27. Sensitivity to vecuronium in myasthenia gravis: A dose-response study
28. Anesthesia for esophageal and mediastinal surgery
29. Predictors of respiratory failure following transcervical thymectomy
30. An electrophysiological investigation of neuromuscular transmission in myasthenia gravis
31. Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome
32. Study of long-term anticholinesterase therapy. Effects on neuro-muscular transmission and on motor endplate line structure
33. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans
34. Clinical experience in more than 2000 patients with myasthenia gravis
35. Postoperative respiratory care after transsternal thymectomy in myasthenia gravis: A 3-year experience in 53 patients
36. Vecuronium in the myasthenic patient
37. Thymectomy for myasthenia gravis: An analysis of the controversies regarding technique and results
38. Thymectomy Task Force of the Medical Advisory Board of the Myasthenia Gravis Foundation of America
39. "Maximal" thymectomy for myasthenia gravis: Results
40. Long-term corticosteroid treatment of myasthenia gravis
41. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers
42. Prediction of the need for postoperative mechanical ventilation in myasthenia gravis
43. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value
44. Immunosuppressive drugs: Azathioprine in the treatment of myasthenia gravis
45. Partial sternotomy approach to the thymus
46. Muscle diseases: Myasthenic gravis
47. Inadequate antagonism of vecuronium-induced neuromuscular block of neostigmine during sevoflurane or isoflurane anesthesia
48. Prognostic factors for myasthenia gravis treated by thymectomy: Review of 61 cases
49. Halothane-induced variability in the neuromuscular transmission of patients with myasthenia gravis
50. Neuromuscular effects of isoflurane in patients with myasthenia gravis
51. Studies on myasthenia gravis: Review of a twenty-year experience in over 1200 patients
52. The margin of safety of neuromuscular transmission
53. Ambient pressure oxygen reservoir apparatus for use during one-lung anaesthesia
54. Plasmapheresis: Technique and complications
55. The electrodiagnosis of myasthenia gravis
56. Recoveries of post-tetanic twitch and train of four responses after administration of vecuronium with different inhalation anesthetics and neurosept anaesthesia
57. Plasmapheresis in myasthenia gravis
58. Cumulative dose-response curves for atracurium in patients with myasthenia gravis
59. Transcervical approach to the thymus
60. The thymus and myasthenia gravis
61. Efficacy and safety of extended thymectomy for elderly patients with myasthenia gravis
62. Sequential changes of arterial oxygen tension in the supine position during one-lung ventilation
63. Morphology of the myasthenic neuromuscular junction
64. VATS Approach to the thymus
65. Maximum thymectomy for myasthenia gravis